Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01389544 · ClinicalTrials.gov registry record · Phase 1
A Study on the Interaction Between Danoprevir/Ritonavir and Methadone
A Phase 1 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01389544 is a Phase 1 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 18 participants.
The verdict
NCT01389544, a Phase 1 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This multicenter, open-label study will assess the effect of multiple doses of danoprevir/ritonavir on steady-state pharmacokinetics of methadone. Subjects on stable methadone maintenance therapy (20 - 120 mg daily as single oral morning dose) will receive danoprevir 100 mg orally twice daily and ritonavir 100 mg orally twice daily for 10 days.
Interventions
- DRUG methadone
- DRUG ritonavir
- DRUG danoprevir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01389544
The ClinicalTrials.gov registry entry for NCT01389544 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which methadone is the first listed.
NCT01389544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01389544 about?
NCT01389544 is a clinical study titled "A Study on the Interaction Between Danoprevir/Ritonavir and Methadone". This multicenter, open-label study will assess the effect of multiple doses of danoprevir/ritonavir on steady-state pharmacokinetics of methadone. Subjects on stable methadone maintenance therapy (20 - 120 mg daily as single oral morning dose) will receive danoprevir 100 mg orally twice daily and ri...
What is the current status of trial NCT01389544?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2011-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01389544?
The interventions under investigation include: methadone (DRUG), ritonavir (DRUG), danoprevir (DRUG).
Who is sponsoring clinical trial NCT01389544?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.